Amelioration of arthritis through mobilization of peptide-specific CD8 regulatory T cells

The Journal of clinical investigation (Impact Factor: 13.22). 02/2013; 123(3). DOI: 10.1172/JCI66938
Source: PubMed


Current therapies to treat autoimmune disease focus mainly on downstream targets of autoimmune responses, including effector cells and cytokines. A potentially more effective approach would entail targeting autoreactive T cells that initiate the disease cascade and break self tolerance. The murine MHC class Ib molecule Qa-1b (HLA-E in humans) exhibits limited polymorphisms and binds to 2 dominant self peptides: Hsp60p216 and Qdm. We found that peptide-induced expansion of tetramer-binding CD8+ Tregs that recognize Qa-1-Hsp60p216 but not Qa-1-Qdm strongly inhibited collagen-induced arthritis, an animal model of human rheumatoid arthritis. Perforin-dependent elimination of autoreactive follicular Th (TFH) and Th17 cells by CD8+ Tregs inhibited disease development. Infusion of in vitro-expanded CD8+ Tregs increased the efficacy of methotrexate treatment and halted disease progression after clinical onset, suggesting an alternative approach to this first-line treatment. Moreover, infusion of small numbers of Qa-1-Hsp60p216-specific CD8+ Tregs resulted in robust inhibition of autoimmune arthritis, confirming the inhibitory effects of Hsp60p216 peptide immunization. These results suggest that strategies designed to expand Qa-1-restricted (HLA-E-restricted), peptide-specific CD8+ Tregs represent a promising therapeutic approach to autoimmune disorders.

Download full-text


Available from: Jianmei W Leavenworth, Feb 06, 2015
1 Follower
27 Reads
  • Source
    • "Sharing some commonalities with CD4+ cells, TCDD-activated Ahr enhances CD25 expression on CD8+ cells, which induces a CTL phenotype termed CD8+ Tregs that are capable of suppressing responder T cells and proinflammatory cytokines [69]. Deregulation of these cells has been recently linked to certain animal models of autoimmunity such as EAE [70], UC [71], and CIA [72]. However, the significance of Ahr in these cells in relevance to autoimmunity is awaiting further investigation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The immune system is regulated by distinct signaling pathways that control the development and function of the immune cells. Accumulating evidence suggest that ligation of aryl hydrocarbon receptor (Ahr), an environmentally responsive transcription factor, results in multiple cross talks that are capable of modulating these pathways and their downstream responsive genes. Most of the immune cells respond to such modulation, and many inflammatory response-related genes contain multiple xenobiotic-responsive elements (XREs) boxes upstream. Active research efforts have investigated the physiological role of Ahr in inflammation and autoimmunity using different animal models. Recently formed paradigm has shown that activation of Ahr by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or 3,3'-diindolylmethane (DIM) prompts the differentiation of CD4(+)Foxp3(+) regulatory T cells (Tregs) and inhibits T helper (Th)-17 suggesting that Ahr is an innovative therapeutic strategy for autoimmune inflammation. These promising findings generate a basis for future clinical practices in humans. This review addresses the current knowledge on the role of Ahr in different immune cell compartments, with a particular focus on inflammation and autoimmunity.
    01/2014; 2014(2-3):520763. DOI:10.1155/2014/520763
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Signaling lymphocytic activation molecule (SLAM)-associated protein (SAP) is a Src homology 2 (SH2) domain-only adaptor involved in multiple immune cell functions. It has also been linked to immunodeficiencies, as well as to autoimmune diseases such as systemic lupus erythematosus. Here, we examined the role and mechanism of action of SAP in autoimmunity using a mouse model of autoimmune arthritis, collagen-induced arthritis (CIA). We found that SAP was essential for development of CIA in response to collagen immunization. It was also required for production of collagen-specific antibodies, which play a key role in disease pathogenesis. These effects required SAP expression in T cells, not in B cells. In mice immunized with a high dose of collagen, the activity of SAP was nearly independent of its ability to bind the protein tyrosine kinase Fyn and correlated with the capacity of SAP to promote full differentiation of follicular T helper (TFH) cells. However, with a lower dose of collagen, the role of SAP was more dependent on Fyn-binding, suggesting that additional mechanisms other than TFH cell differentiation were involved. Further studies suggested that this might be due to a role of the SAP-Fyn interaction in natural killer (NK)-T cell development, through the ability of SAP-Fyn to promote Vav-1 activation. We also found that removal of SAP expression during progression of CIA attenuated disease severity. However, it had no effect on disease once CIA was clinically established. Together, these results indicate that SAP plays an essential role in CIA, due to Fyn-independent and Fyn-dependent effects on TFH cells and, possibly, other T cell types.
    Journal of Biological Chemistry 09/2013; 288(44). DOI:10.1074/jbc.M113.473736 · 4.57 Impact Factor
  • Source
    12/2013; 2(4):554-586. DOI:10.3390/antib2040554
Show more